CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 500 of 764 entries

View as:

A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Phase: N/A Priority: Normal

NCT ID: NCT02240875 Org: User:

Start: 09/17/14 End: 08/22/17 Due: 08/22/18

Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909

Phase: N/A Priority: Normal

NCT ID: NCT01351948 Org: User:

Start: 06/30/11 End: 03/31/13 Due: 03/31/14

VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum Infection

Phase: N/A Priority: Normal

NCT ID: NCT03906474 Org: User:

Start: 11/06/18 End: 02/14/19 Due: 02/14/20

Statin Therapy In Cardiac Surgery

Phase: N/A Priority: Normal

NCT ID: NCT01573143 Org: User:

Start: 09/30/11 End: 09/30/14 Due: 09/30/15

Effort and Antidepressant Study Test

Phase: N/A Priority: Normal

NCT ID: NCT06696482 Org: User:

Start: 01/31/25 End: 09/30/25 Due: 09/30/26

A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.

Phase: N/A Priority: Normal

NCT ID: NCT03923725 Org: User:

Start: 09/01/20 End: 09/30/24 Due: 09/30/25

SCOOT: Sample Collection for DART

Phase: N/A Priority: Normal

NCT ID: NCT05368298 Org: User:

Start: 08/11/22 End: 12/31/25 Due: 12/31/26

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines

Phase: N/A Priority: Normal

NCT ID: NCT05951595 Org: User:

Start: 01/01/24 End: 05/31/25 Due: 05/31/26

Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines

Phase: N/A Priority: Normal

NCT ID: NCT01432158 Org: User:

Start: 01/31/12 End: - Due: -

A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Phase: N/A Priority: Normal

NCT ID: NCT02296983 Org: User:

Start: 12/31/14 End: 09/30/16 Due: 09/30/17

Aetiology of TemporaL Arteritis Study

Phase: N/A Priority: Normal

NCT ID: NCT02584517 Org: User:

Start: 01/31/16 End: 01/31/21 Due: 01/31/22

Gene Therapy for Blindness Caused by Choroideremia

Phase: N/A Priority: Normal

NCT ID: NCT01461213 Org: User:

Start: 10/31/11 End: 10/31/17 Due: 10/31/18

Prevention of Mood Disorders by Folic Acid Supplementation

Phase: N/A Priority: Normal

NCT ID: NCT00459264 Org: User:

Start: 12/31/05 End: 12/31/11 Due: 12/31/12

Advanced Ultrasound in Pleural Infection

Phase: N/A Priority: Normal

NCT ID: NCT02608814 Org: User:

Start: 05/31/15 End: 03/14/17 Due: 03/14/18

Thymoglobulin Induction in Kidney Transplant Recipients

Phase: N/A Priority: Normal

NCT ID: NCT01239563 Org: User:

Start: 01/31/11 End: 05/31/16 Due: 05/31/17

A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates

Phase: N/A Priority: Normal

NCT ID: NCT01623557 Org: User:

Start: 04/30/12 End: 11/30/12 Due: 11/30/13

A Study to Compare Two Dosing Regimens for a New Malaria Vaccine

Phase: N/A Priority: Normal

NCT ID: NCT06141057 Org: User:

Start: 06/06/23 End: 07/31/25 Due: 07/31/26

Research on Community Based ATK Test Study to Control Spread of COVID-19 in Migrant Community

Phase: N/A Priority: Normal

NCT ID: NCT05557513 Org: User:

Start: 08/18/22 End: 12/31/22 Due: 12/31/23

REward Processing And Citalopram Study

Phase: N/A Priority: Normal

NCT ID: NCT06017037 Org: User:

Start: 05/19/23 End: 05/01/24 Due: 05/01/25

Baby-CINO: CaffeINe Treatment Optimisation in Premature Infants

Phase: N/A Priority: Normal

NCT ID: NCT06416956 Org: User:

Start: 12/11/23 End: 09/01/24 Due: 09/01/25

A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00480688 Org: User:

Start: 11/30/01 End: 05/31/02 Due: 05/31/03

Using Electroencephalography (EEG) and Transcranial Current Stimulation (tCS) to Study and Modulate Cognition Study

Phase: N/A Priority: Normal

NCT ID: NCT03293316 Org: User:

Start: 11/30/15 End: 10/31/16 Due: 10/31/17

A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant

Phase: N/A Priority: Normal

NCT ID: NCT02925403 Org: User:

Start: 08/26/16 End: 02/15/17 Due: 02/15/18

The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.

Phase: N/A Priority: Normal

NCT ID: NCT05942287 Org: User:

Start: 05/24/23 End: 12/31/26 Due: 12/31/27

OptiGon - Optimising Laboratory Assays for Immune Responses to Gonococcus

Phase: N/A Priority: Normal

NCT ID: NCT05613725 Org: User:

Start: 12/02/22 End: 04/30/24 Due: 04/30/25

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo	NCT02240875	University of Oxford	user2@example.com	None	2014-09-17	2017-08-22	2018-08-22	-	-	2025-07-14
Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909	NCT01351948	University of Oxford	user2@example.com	None	2011-06-30	2013-03-31	2014-03-31	-	-	2025-07-14
VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum Infection	NCT03906474	University of Oxford	user2@example.com	None	2018-11-06	2019-02-14	2020-02-14	-	-	2025-07-14
Statin Therapy In Cardiac Surgery	NCT01573143	University of Oxford	user2@example.com	None	2011-09-30	2014-09-30	2015-09-30	-	-	2025-07-14
Effort and Antidepressant Study Test	NCT06696482	University of Oxford	user2@example.com	None	2025-01-31	2025-09-30	2026-09-30	-	-	2025-07-14
A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.	NCT03923725	University of Oxford	user2@example.com	None	2020-09-01	2024-09-30	2025-09-30	-	-	2025-07-14
SCOOT: Sample Collection for DART	NCT05368298	University of Oxford	user2@example.com	None	2022-08-11	2025-12-31	2026-12-31	-	-	2025-07-14
A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines	NCT05951595	University of Oxford	user2@example.com	None	2024-01-01	2025-05-31	2026-05-31	-	-	2025-07-14
Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines	NCT01432158	University of Oxford	user2@example.com	None	2012-01-31	-	-	-	-	2025-07-14
A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.	NCT02296983	University of Oxford	user2@example.com	None	2014-12-31	2016-09-30	2017-09-30	-	-	2025-07-14
Aetiology of TemporaL Arteritis Study	NCT02584517	University of Oxford	user2@example.com	None	2016-01-31	2021-01-31	2022-01-31	-	-	2025-07-14
Gene Therapy for Blindness Caused by Choroideremia	NCT01461213	University of Oxford	user2@example.com	None	2011-10-31	2017-10-31	2018-10-31	-	-	2025-07-14
Prevention of Mood Disorders by Folic Acid Supplementation	NCT00459264	University of Oxford	user2@example.com	None	2005-12-31	2011-12-31	2012-12-31	-	-	2025-07-14
Advanced Ultrasound in Pleural Infection	NCT02608814	University of Oxford	user2@example.com	None	2015-05-31	2017-03-14	2018-03-14	-	-	2025-07-14
Thymoglobulin Induction in Kidney Transplant Recipients	NCT01239563	University of Oxford	user2@example.com	None	2011-01-31	2016-05-31	2017-05-31	-	-	2025-07-14
A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates	NCT01623557	University of Oxford	user2@example.com	None	2012-04-30	2012-11-30	2013-11-30	-	-	2025-07-14
A Study to Compare Two Dosing Regimens for a New Malaria Vaccine	NCT06141057	University of Oxford	user2@example.com	None	2023-06-06	2025-07-31	2026-07-31	-	-	2025-07-14
Research on Community Based ATK Test Study to Control Spread of COVID-19 in Migrant Community	NCT05557513	University of Oxford	user2@example.com	None	2022-08-18	2022-12-31	2023-12-31	-	-	2025-07-14
REward Processing And Citalopram Study	NCT06017037	University of Oxford	user2@example.com	None	2023-05-19	2024-05-01	2025-05-01	-	-	2025-07-14
Baby-CINO: CaffeINe Treatment Optimisation in Premature Infants	NCT06416956	University of Oxford	user2@example.com	None	2023-12-11	2024-09-01	2025-09-01	-	-	2025-07-14
A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers	NCT00480688	University of Oxford	user2@example.com	None	2001-11-30	2002-05-31	2003-05-31	-	-	2025-07-14
Using Electroencephalography (EEG) and Transcranial Current Stimulation (tCS) to Study and Modulate Cognition Study	NCT03293316	University of Oxford	user2@example.com	None	2015-11-30	2016-10-31	2017-10-31	-	-	2025-07-14
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant	NCT02925403	University of Oxford	user2@example.com	None	2016-08-26	2017-02-15	2018-02-15	-	-	2025-07-14
The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.	NCT05942287	University of Oxford	user2@example.com	None	2023-05-24	2026-12-31	2027-12-31	-	-	2025-07-14
OptiGon - Optimising Laboratory Assays for Immune Responses to Gonococcus	NCT05613725	University of Oxford	user2@example.com	None	2022-12-02	2024-04-30	2025-04-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance